DI > Ekonomi

Thursday, 25 February, 11:00

DI - 22 jan 21 kl. 07:10

Nanoform’s Clinical Study Indicates Positive Interim Results




Läs mer på DI
Läs mer om:
Clinical Study Indicates Positive Interim Results

Dela artikeln

delningar på Facebook.

Liknande nyheter

Taggar: Nanoforms , Clinical, Study, Indicates, Positive, Interim, Results
DI - 21 jun 18 kl. 11:33

Xspray Pharma gets go-ahead from the Swedish MPA for clinical study

Xspray Pharma has obtained approval from the Swedish Medical Products Agency (MPA) to carry out a previously announced clinical study of the formulation of the company’s product candidate HyNap-Dasa. The study is part of Xspray’s clinical program and will be completed during the third quarter. The objective is to confirm the bioequivalence of the optimized formulation developed by Xspray, based on the company’s patented RightSize-technology.

DI - 29 jun 20 kl. 07:49

SynAct Pharma has initiated the Phase II clinical study with AP1189 in Nephrotic Syndrome

SynAct Pharma AB ("SynAct") today announced that the company has initiated a Phase II clinical study with the AP1189 compound in idiopathic….

DI - 18 dec 18 kl. 14:30

First patient enrolled in Isofol’s Pivotal Phase 3 AGENT study in 1st line metastatic colorectal cancer

GOTHENBURG, Sweden, December 18, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL) today announced that the first patient has been enrolled in the pivotal Phase 3 AGENT clinical study evaluating arfolitixorin for the treatment of metastatic colorectal cancer (mCRC). AGENT is a randomized, controlled, multi-centre study with blinded independent review of the tumour response.    .

The Local - 21 jun 14 kl. 14:32

Swedish agency clears paedophilia study

The Swedish Medical Products Agency (Läkemedelsverket) has approved a clinical study into the use of drugs to tackle paedophilia in the wake of a high-profile daycare rape case..

DI - 07 jul 20 kl. 11:10

Lipidor signs agreement with CRO for implementation of Phase III clinical study of drug candidate AKP-02 against Psoriasis

Lipidor AB (Nasdaq First North: LIPI) today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company….

The Local - 23 jan 12 kl. 07:18

Hip fat indicates health risk: study

Health risks for people with broad hips and narrow waist are significantly lower than for those with narrow hips and broad waist, according to a new international study on obesity, led by cardiology specialists at Umeå University..

DI - 15 nov 18 kl. 08:00

Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer

GOTHENBURG, Sweden, November 15, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL) today announced initiation of the pivotal Phase 3 clinical trial, the ISO-CC-007 study, for the treatment of first-line (initial) metastatic colorectal cancer (mCRC)..

DI - 03 sep 20 kl. 08:52

SynAct Pharma informs that the recruitment to part 1 in the Clinical Phase II study with AP1189 in Rheumatoid Arthritis is completed

SynAct Pharma AB ("SynAct") today announces that recruitment to the second cohort in part 1 of the company’s Phase IIa study in patients….

DI - 06 aug 20 kl. 08:10

Nanoform convenes EGM to elect Cynthia Schwalm as board member

COMPANY RELEASE August 6, 2020 9:10 am Helsinki time Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle….

DI - 28 aug 20 kl. 07:10

Nanoform finland plc, 2020 half year financial report, 28 august 2020 at 8:10 am eest

COMPANY RELEASE NANOFORM FINLAND PLC, 2020 HALF YEAR FINANCIAL REPORT, 28 AUGUST 2020 AT 8:10 AM EEST Nanoform’s half year financial report….

DI - 04 jun 20 kl. 09:17

Nanoform rusar 20 procent i First North-debuten

Det finländska forskningsbolaget Nanoform klättrar 20 procent i debuten på First North..

Pressen.se i Sociala medier

Pressen på facebook Nyhetspressen på Twitter

Liknande Nyheter

Bilder


Prenumerera på nyheter (RSS)

RSS är ett enklare sätt att följa nyheterna. Nyheterna laddas automatiskt ner till din nyhetsläsare och du behöver inte gå in på Pressen.se.

Du får gärna publicera eller länka till RSS-flödet på din blogg eller hemsida.



?>


Om oss

Pressen.se är en svensk nyhetsportal samt nyhetssökmotor som automatiskt hittar de mest omdiskuterade och aktuella nyheterna. Välkommen!

Kontakt

Vill du säga hej?

Reklam

Annonsera?Pressen.se besöks hundratusentals gånger per månad. Kontakta oss för mer information om hur du kan nå ut med ditt budskap.